Design Features that Affect Psychopharmacology Trials

Title: Design Features that Affect Psychopharmacology Trials

Volume: 2 Issue: 7

Author(s): Arif Khan and Kelly Schwartza

Affiliation:

Keywords: investigational psychopharmacological agent, Antidepressant, placebo, Clinical Trials, obsessive compulsive disorder (OCD)

Abstract: The patients psychiatric diagnoses play a large role in the design and outcome of psychopharmacology clinical trials. Among antidepressant trials, magnitude of placebo response, initial severity of depression, dosing regimen, number of treatment arms and duration of trial, choice of rating scales, and sex of the patient may influence antidepressant trial outcome.

Cite this article as:

Khan Arif and Schwartza Kelly, Design Features that Affect Psychopharmacology Trials, Letters in Drug Design & Discovery 2005; 2 (7) . https://dx.doi.org/10.2174/157018005774479140